During the past decade, Temple University Hospital conducted 199 clinical trials. In the 10-year time frame, 199 clinical trials started and 142 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 90 clinical trials started and 92 clinical trials were completed. i.e. 102.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Temple University Hospital" #1 sponsor was "Temple University" with 40 trials, followed by "National Cancer Institute (NCI)" with 34 trials sponsored, "SWOG Cancer Research Network" with 24 trials sponsored, "Actelion" with 10 trials sponsored and "Gynecologic Oncology Group" with 10 trials sponsored. Other sponsors include 241 different institutions and companies that sponsored additional 146 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Temple University Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 67 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 15 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 12 trials as a collaborator and "Medical University of South Carolina" with 10 trials as a collaborator. Other collaborators include 170 different institutions and companies that were collaborators in the rest 132 trials.

According to Clinical.Site data, the most researched conditions in "Temple University Hospital" are "COVID-19" (11 trials), "Pulmonary Arterial Hypertension" (10 trials), "Heart Failure" (9 trials), "Gastroparesis" (8 trials) and "Chronic Obstructive Pulmonary Disease" (7 trials). Many other conditions were trialed in "Temple University Hospital" in a lesser frequency.

Most popular intervention types in "Temple University Hospital" are "Drug" (234 trials), "Other" (95 trials), "Biological" (53 trials), "Device" (53 trials) and "Procedure" (41 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (59 trials), "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (31 trials), "Paclitaxel" (21 trials) and "Carboplatin" (19 trials). Other intervention names were less common.

The vast majority of trials in "Temple University Hospital" are 321 trials for "All" genders, 35 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Temple University Hospital". 1 are not yet recruiting, 58 are recruiting, 63 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 179 completed trials in Temple University Hospital, 1 suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in Temple University Hospital, 11 "Phase 1" clinical trials were conducted, 105 "Phase 2" clinical trials and 157 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 57 trials that are defined as “Not Applicable".